Arrowhead Pharmaceuticals
ARWR
£11.92
Share price
-1.73%
Change (1 day)
-46.60%
Change (1 year)
Categories
Market capitalization of Arrowhead Pharmaceuticals (ARWR)
Market cap: £1.64 Billion
As of July 2025 Arrowhead Pharmaceuticals has a market cap of £1.64 Billion. This makes Arrowhead Pharmaceuticals the world's 4431th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Arrowhead Pharmaceuticals from 1997 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | £1.64 B | -12.43% |
| 2024 | £1.88 B | -27.14% |
| 2023 | £2.58 B | -32.37% |
| 2022 | £3.81 B | -25.68% |
| 2021 | £5.13 B | -11.24% |
| 2020 | £5.78 B | 18.27% |
| 2019 | £4.89 B | 439.86% |
| 2018 | £0.90 B | 344.64% |
| 2017 | £0.20 B | 118.67% |
| 2016 | £93.17 M | -62.35% |
| 2015 | £0.24 B | -4.59% |
| 2014 | £0.25 B | 1.1% |
| 2013 | £0.25 B | 1138.56% |
| 2012 | £20.71 M | -27% |
| 2011 | £28.37 M | -31.84% |
| 2010 | £41.63 M | 102.44% |
| 2009 | £20.56 M | -23.7% |
| 2008 | £26.95 M | -63.41% |
| 2007 | £73.66 M | -3.77% |
| 2006 | £76.54 M | -7.5% |
| 2005 | £82.75 M | 160.54% |
| 2004 | £31.76 M | 53692.92% |
| 2003 | £0.05 M | 199.13% |
| 2002 | £0.01 M | -63.83% |
| 2001 | £0.05 M | -74.58% |
| 2000 | £0.21 M | 38.28% |
| 1999 | £0.15 M | -2.01% |
| 1998 | £0.15 M | 62.96% |
| 1997 | £0.09 M |
End of Day market cap according to different sources
On Jul 29th, 2025 the market cap of Arrowhead Pharmaceuticals was reported to be:
£1.64 Billion
£1.64 Billion
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 Alnylam Pharmaceuticals
ALNY | £32.27 B | 1,860.37% | 🇺🇸 USA |
 Dicerna Pharmaceuticals DRNA | £2.22 B | 35.44% | 🇺🇸 USA |
 Ligand Pharmaceuticals LGND | £1.90 B | 15.47% | 🇺🇸 USA |
 Inovio Pharmaceuticals INO | £54.56 M | -96.69% | 🇺🇸 USA |
 Johnson & Johnson JNJ | £303.16 B | 18,315.12% | 🇺🇸 USA |
 Moderna
MRNA | £9.45 B | 474.51% | 🇺🇸 USA |